Mediar gets a spark from Pfizer s Ignite program fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Mediar Therapeutics raises $85 million to develop drugs for diseases that cause scarring in organs; Bellicum Pharmaceuticals halted its Phase I/II trials after a serious adverse event; The Food and Drug Administration says Paxlovid is not associated with COVID rebound.
/PRNewswire/ Mediar Therapeutics Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt and even reverse the course of.